title: Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.
abstract: By using target cells that expressed isolated env, gag, p27nef, or p23vif molecules introduced by recombinant vaccinia viruses containing genes encoding these polypeptides, it was possible to identify env, gag, p27nef, and p23vif as cytolytic target antigens for freshly isolated blood cells from human immunodeficiency virus 1 (HIV-1) seropositive patients. Most of the patients tested (95%) manifested a specific cytotoxic activity against vaccinia virus-env-infected target cells. The env-specific cytotoxic activity was not restricted by the major histocompatibility complex and was not mediated by T lymphocytes, as shown by the absence of blocking effect with an anti-CD3 monoclonal antibody and by the inefficiency of CD3+, CD8+, or CD4+ and CD8+ depletion to reduce the cytotoxic activity against the env-expressing target cells. In the same conditions, the cytotoxic activity specific for gag was abrogated and gag major histocompatibility complex-restricted cytotoxic T lymphocytes were detected in 85% of the subjects tested. Therefore, in a HIV-1 seropositive subject, distinct types of effector cells mediate the lysis of target cells expressing gag and env proteins.
authors.affiliation: Viral Oncology Unit, Institut Pasteur, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Riviere
authors.forename: F
authors.initials: F
authors.lastname: Tanneau-Salvadori
authors.forename: A
authors.initials: A
authors.lastname: Regnault
authors.forename: O
authors.initials: O
authors.lastname: Lopez
authors.forename: P
authors.initials: P
authors.lastname: Sansonetti
authors.forename: B
authors.initials: B
authors.lastname: Guy
authors.forename: M P
authors.initials: MP
authors.lastname: Kieny
authors.forename: J J
authors.initials: JJ
authors.lastname: Fournel
authors.forename: L
authors.initials: L
authors.lastname: Montagnier
mesh_terms: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D017252:CD3 Complex; D016827:CD8 Antigens; D003602:Cytotoxicity, Immunologic; D015683:Gene Products, gag; D006679:HIV Seropositivity / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D008285:Major Histocompatibility Complex; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D012191:Retroviridae Proteins / Q000276:immunology*; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology; D014759:Viral Envelope Proteins / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D016827:CD8 Antigens; D015683:Gene Products, gag; D011948:Receptors, Antigen, T-Cell; D012191:Retroviridae Proteins; D014759:Viral Envelope Proteins